Page 1906 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Index 1333

Caregivers, care of, in intensive-care unit and Central venous pressure (CVP), 250, 1144 Cholangitis, 999–1000, 1000f
after critical illness, 114–116 head injury and, 1126 acute, 1080
Caspofungin, 621 sepsis and, 569 Cholecystitis
Catecholamines, 315 Cephalic tetanus, 730 acalculous, 1000, 1080
Category B agents, 751 Cephalosporins, 546–547, 549t, 550 sepsis and, 567
Catheter-associated bacteriuria and extended spectrum, 612 Cholecystostomy, percutaneous,
candiduria, 702–703 Cerebral blood flow, head injury and, 212–214, 213f, 214f
Catheter-associated urinary tract infection 1130–1131, 1130f Cholestasis, 566
(CAUTI), 696 Cerebral edema, 774, 976, 1025 parenteral nutrition-associated, 1000–1001
Catheter colonization, 591 mass effect and, 794–795, 794t, 795f Chronic critical illness, 97–103, 97t
Catheter-directed arterial and venous Cerebral infarction, 773–775, 773t, 774t communication of outcomes,
thrombolysis, 216, 217f, 218 Cerebral microdialysis, 1132 102–103, 103t
Catheter fracture and migration, 225, 225f Cerebral oxygenation and metabolism, head incidence, 97–98, 98f
Catheter management, in percutaneous injury and, 1131–1132 management of
nephrostomy, 212 Cerebral perfusion pressure, head injury airway management of, 100
Catheter misplacement, 185 and, 1130 alternative sites of care, 101
Catheter occlusion, 185 Cerebral pressure reactivity (PRx), 804 infection control, 99
Catheter-related blood stream infection Cerebral salt wasting (CSW), 948, 1128 liberation from mechanical
(CR-BSI), 13–14, 558 Cerebrospinal fluid drains, 1062–1063, ventilation, 100
Caval thrombosis, 223 1063–1065t nutrition, 99–100
Cavernous sinus thrombosis, 597, 687 Cerebrovascular disease, 770–778 physical and occupational therapy,
CD4+ lymphocyte count, 626 clinical and laboratory diagnosis of, 100–101
Cefazolin, 546 771–773 psychological support, 101
Cefepime, 546–547 etiology of, 771 outcomes
Cefotaxime, 546 treatment of costs, 102
Cefoxitin, 546 cerebral infarction, 773–775, 773t, 774t function and quality of life, 101–102
Ceftazidime, 546 intracerebral hemorrhage, 775, 776t survival, 101
Ceftriaxone, 546 subarachnoid hemorrhage due to pathophysiology of chronic critical illness,
Cefuroxime, 546 ruptured intracranial aneurysm, neuroendocrine model, 98–99, 99t
Cellular necrosis, 1124 775–778 risk factors, 98, 98t
Cellulitis, 690–691 Certified Health IT Product List (CHPL), 55 Chronic graft-versus-host disease
anaerobic, 691 Cervical spine clearance, spinal injuries (GVHD), 885
sepsis and, 567 and, 1150 Chronic liver failure, 1097–1098
Centers for Disease Control and Cervical spine subluxation, rheumatoid Chronic lung allograft dysfunction
Prevention (CDC), 57 arthritis and, 1244–1245 (CLAD), 1096
initiation of Study on Efficacy of CESAR (Conventional Ventilatory Support Chronic lung diseases, in pregnancy, 1265
Nosocomial Infection Control versus ECMO for Severe Adult Chronic obstructive pulmonary disease,
(SENIC), 23–24 Respiratory Failure) Trial, 478 332, 1090
Centers for Medicare and Medicaid Chance, research concepts relevant to quality Chronic respiratory failure, acute
Services, 11 measurement and, 9, 9t exacerbation, 379–381
Central cord syndrome, 1149–1150 Chance fractures and dislocations, 1138 Chronic vasodilator therapy, 348
Central Data Repository (CDR), 55 Chapare hemorrhagic fever, 739 Circadian rhythmicity in critically ill patient,
Central nervous system Chart review in infection control, 23 158–159
bacterial infections of, 651–664 Chemokines, 565 Circulating biomarkers in diagnosing right
brain abscess, 658–661 Chemotherapy, toxicities of, 891–902 heart syndromes, 312
meningitis, 652–658 by organ system, 893–902, 894t, 895t, 896t, Circulating mediators, measurement of, 554
subdural empyema and epidural 898t, 899t, 900t Circulation, 251–252, 252f
abscess, 661–663 review of anticancer therapies, assessing, 242–248
suppurative intracranial 891–892, 892t arterial pulse contour analysis and
thrombophlebitis, 663–664 Chemotherapy-induced dermatoses, cardiac output, 247–248, 247f
disease in, 560 1284–1285, 1284t, 1285ft cardiac output, 245–248, 246f, 247f
sepsis in, 566 Chest roentography, 505 functional hemodynamic
Central nervous system (CNS), dysfunction Chest tubes, 505, 507–509, 1062–1063, monitoring, 248
in, 1246–1247 1063–1065t tissue oxygenation, 242–245, 243f,
Central nervous system (CNS) leukemia, management of, 508–509 244t, 245f
867–868 Cheyne-Stokes respiration, 832 in burn patients, 1182, 1183f, 1184f
Central pulse oximetry, 243 Chickenpox, 1302 pathophysiology of, in critical illness,
Central transtentorial herniation, 795f, 797 Child-Pugh classification, 223, 225, 228–241, 229f, 230f, 231ft, 233f,
Central venous catheters, 24–25, 24t, 1010, 1011t 234f, 236t, 238f, 239f, 240ft, 241f
242, 268 Children, seizures in, 785–786 Circulatory arrest, 1068
infectious complications of, 182–183 Chlamydia, 676 Circulatory disorders of pregnancy,
mechanical complications of, 183–185 Chloramphenicol, 699 1256–1264, 1256t, 1257ft, 1258t,
Central venous catheters in burn Chloride-resistant disorders, acid-base 1260t, 1262t, 1266t
patients, 1186 balance and, 973–974 Circulatory shock, 243
Central venous line infections, 598–599, 598t Chloride-responsive disorders, acid-base Circulatory system, adaptation of, in
Central venous oxygen saturation, 250 balance and, 973 pregnancy, 1254–1255, 1254t

Index.indd 1333 23-01-2015 15:33:51